GlaxoSmithKline’s widely used diabetes drug Avandia should be pulled off the market, a U.S. Food and Drug Administration scientist said in a presentation prepared for delivery on Monday.
*For more on this story,
read the full Reuters article.
GlaxoSmithKline’s widely used diabetes drug Avandia should be pulled off the market, a U.S. Food and Drug Administration scientist said in a presentation prepared for delivery on Monday.
*For more on this story,
read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99